TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nakamura Läkarkonsult AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
245
|
173
|
180 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
245
|
40
|
61 |
EBITDA |
245
|
40
|
61 |
Total assets |
0
|
181
|
198 |
Current assets |
0
|
181
|
198 |
Current liabilities |
0
|
20
|
23 |
Equity capital |
250
|
161
|
175 |
- share capital |
5
|
4
|
5 |
Employees (average) |
3
|
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
89.0%
|
88.4% | |
Turnover per employee |
82
|
173
|
180 |
Profit as a percentage of turnover |
100%
|
23.1%
|
33.9% |
Return on assets (ROA) |
22.1%
|
30.8% | |
Current ratio |
905.0%
|
860.9% | |
Return on equity (ROE) |
98.0%
|
24.8%
|
34.9% |
Change turnover |
71
|
8
|
-7 |
Change turnover % |
41%
|
5%
|
-4% |
Chg. No. of employees |
2
|
0
![]() |
0 |
Chg. No. of employees % |
200%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.